Psychiatrist-St. Louis (1099)-Greenbrook

Greenbrook; St. Louis (MO); Sur place; USD 100 000 - 130 000; Temps partiel

Avantages offerts par ce poste

TMS certification

No nights/weekends

Flexible part-time

Competitive pay

Résumé du poste

Greenbrook Mental Wellness Centers in St. Louis, MO is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the Spravato (esketamine) program.

This flexible part-time position (1099) offers no nights, weekends, or on-call, competitive compensation, and TMS certification/training provided. Join a collaborative clinical and operational team making a meaningful impact on patients with

Qualifications

• MD or DO required.
• Board Certified or Board Eligible.
• Active Missouri medical license or ability to obtain.
• DEA registration or ability to obtain.

Responsabilités

• Provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments.
• Support growth of the Spravato (esketamine) program in St. Louis, MO.
• Collaborate with clinical and operational teams to ensure safe patient care.

Connaissances

Interventional psychiatry

Formation

MD or DO

Outils

MD license

Description du poste

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato (esketamine) program in St. Louis, MO.

Why Join Us?

• Flexible part-time schedule (1099)
• No nights, weekends, or on-call responsibilities
• Competitive compensation
• TMS certification and training provided
• Opportunity to expand your expertise in interventional psychiatry
• Collaborative clinical and operational support team
• Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders

Qualifications

• MD or DO
• Board Certified or Board Eligible
• Active Missouri medical license (or ability to obtain)
• DEA registration (or ability to obtain)

About Greenbrook

As a leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder (MDD) and related conditions, Greenbrook has delivered over 1.3 million treatments to 40,000+ patients. Our mission is to transform mental health care and improve lives through innovative solutions.

Depression affects more than 16 million Americans. At Greenbrook, we're changing the way it's treated-and you can be part of that change.

Learn more:

• https://youtu.be/yrr-wlFftT0
• https://www.greenbrooktms.com/patient-stories
• https://www.greenbrookproviders.com

GBSP25

About Us

Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar TMS and Spravato therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we're expanding access to life-changing care-combining cutting-edge technology with clinical expertise to make a real impact in the mental health space.